Mobile Menu

Round-up: COVID-19 June 2021 (Part One)

Keeping up with all of the most recent news surrounding the novel coronavirus can be difficult, so we have done it for you in our latest round-up.

Statistics

At the time of writing, there have been:

  • 175,209,828 cases
  • 3,778,085 deaths
  • 158,732,706 recoveries

Research

  • A recent analysis has identified global hotspots where new coronaviruses may likely arise. (Rulli et al, 2021)
  • Scientists have discovered a mechanism by which SARS-CoV-2 exploits changes in metal ion concentrations to evade immune surveillance. (Viswanathan et al, 2021)
  • New preclinical research has found that a nasal therapy based on new IgM antibodies is more effective than commonly used IgG antibodies at neutralising the virus. (Ku et al, 2021)
  • An extensive study has identified over a dozen existing drugs that could be repurposed for COVID-19. (Bakowski et al, 2021)
  • Researchers have found that a high concentration of ACE2 in the blood may increase the risk of serious COVID-19 infection. (Kragstrup et al, 2021)
  • New research has found a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP), a potential new therapeutic anti-viral target. (Gutmann et al, 2021)
  • Researchers have shown that COVID-19 exacerbates the damaging impact of senescent cells in the body. Additionally, they found that senolytic drugs reduced inflammation, illness and mortality from infection in older mice. (Camell et al, 2021)
  • A meta-transcriptomic study of bat samples has identified four novel SARS-CoV-2 related and three SARS-CoV related viruses. (Zhou et al, 2021)

Other news

  • A group of experts has proposed the ‘five Cs’ to tackle vaccine hesitancy. These include confidence, complacency, convenience, communication and context. (Razai et al, 2021)
  • A recent Nature article has examined the arguments that the novel coronavirus escaped from a lab in China. (Maxmen and Mallapaty, 2021)
  • New findings show that a single dose of the Johnson & Johnson vaccine is able to generate a robust immune response against all viral variants. (Alter et al, 2021)

Image credit: By starline – freepik


More on these topics

Coronavirus / covid-19 / Vaccine

Share this article